2501:TSESapporo Holdings Limited Analysis
Data as of 2026-06-25 - not real-time
¥2,038.50
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is displaying a classic overbought signal with a very high RSI, while the MACD remains bullish but may be losing momentum as price hovers at a strong resistance level. Valuation pressure is evident as the market price sits far above the discounted cash‑flow derived fair value, and the trailing P/E is markedly elevated compared to typical industry levels. Fundamental health is mixed; operating margins are negative, debt levels are high relative to equity, and free cash flow is essentially zero despite solid operating cash generation. Dividend sustainability is questionable given the sizable payout ratio and the balance sheet strain. Liquidity appears adequate with stable trading volumes, but the stock’s beta is slightly negative, suggesting an inverse reaction to broader market moves. Overall sentiment leans toward caution as the price approaches its 52‑week high amid elevated volatility.
The medium‑term picture does not improve significantly: the company’s core brands remain strong in the consumer defensive beverage space, offering a modest dividend yield, yet the earnings outlook is muted by weak profitability and a heavy debt burden. Risk factors include high valuation disparity, sector‑specific regulatory exposure, and the potential for a price correction given the technical overbought condition. Investors should weigh the attractive dividend against the sustainability concerns and the likelihood of a near‑term pullback. Recommendation leans toward a defensive stance, favoring reduction of exposure rather than new accumulation.
The medium‑term picture does not improve significantly: the company’s core brands remain strong in the consumer defensive beverage space, offering a modest dividend yield, yet the earnings outlook is muted by weak profitability and a heavy debt burden. Risk factors include high valuation disparity, sector‑specific regulatory exposure, and the potential for a price correction given the technical overbought condition. Investors should weigh the attractive dividend against the sustainability concerns and the likelihood of a near‑term pullback. Recommendation leans toward a defensive stance, favoring reduction of exposure rather than new accumulation.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- RSI in overbought territory
- Price at strong resistance
- Significant overvaluation versus DCF
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable dividend yield
- High debt load
- Neutral technical trend
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong brand presence in consumer defensive sector
- Weak profitability and operating margins
- Uncertain dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth-8.20%
Profit Margin4.55%
P/E Ratio52.9
Debt/Equity96.14
P/B Ratio3.7
Op. Cash Flow¥37.4B
Technical Analysis
TrendNeutral
RSI80.0
Support¥1,533.00
Resistance¥2,040.00
MA 20¥1,710.10
MA 50¥1,723.27
MA 200¥1,634.77
MACDBullish
VolumeStable
Fear & Greed Index89.29
Valuation
Fair Value¥404.87
Target Price¥1,264.00
Upside/Downside-37.99%
GradeOvervalued
TypeValue
Dividend Yield2.05%
Risk Assessment
Beta-0.16
Volatility34.83%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.